Skip to Main Content

Author Details

Joshua Armenia
Oncology R&D
2013
42
30
PMIDPaper TitleJournal TitlePublished Year
37434977Impact of DNA damage repair alterations on prostate cancer progression and metastasis.Front Oncol2023
34710570Phase II study of ceralasertib (AZD6738) in combination with durvalumab in patients with advanced/metastatic melanoma who have failed prior anti-PD-1 therapy.Ann Oncol2022
35756843PARP inhibition is a modulator of anti-tumor immune response in BRCA-deficient tumors.Oncoimmunology2022
36969741Drug-gene Interaction Screens Coupled to Tumor Data Analyses Identify the Most Clinically Relevant Cancer Vulnerabilities Driving Sensitivity to PARP Inhibition.Cancer Res Commun2022
35921524Identification of a Molecularly-Defined Subset of Breast and Ovarian Cancer Models that Respond to WEE1 or ATR Inhibition, Overcoming PARP Inhibitor Resistance.Clin Cancer Res2022
33091561A meta-analysis of reversion mutations in BRCA genes identifies signatures of DNA end-joining repair mechanisms driving therapy resistance.Ann Oncol2021
34158341Radiopotentiation Profiling of Multiple Inhibitors of the DNA Damage Response for Early Clinical Development.Mol Cancer Ther2021
33339894SLFN11 informs on standard of care and novel treatments in a wide range of cancer models.Br J Cancer2021
32385899Ribonucleotide reductase small subunit M2 is a master driver of aggressive prostate cancer.Mol Oncol2020
31953314Adenosine Signaling Is Prognostic for Cancer Outcome and Has Predictive Utility for Immunotherapeutic Response.Clin Cancer Res2020
31796516Significance of <i>BRCA2</i> and <i>RB1</i> Co-loss in Aggressive Prostate Cancer Progression.Clin Cancer Res2020
33015525Dickkopf-1 Can Lead to Immune Evasion in Metastatic Castration-Resistant Prostate Cancer.JCO Precis Oncol2020
30333152Genetic and Epigenetic Determinants of Aggressiveness in Cribriform Carcinoma of the Prostate.Mol Cancer Res2019
31225930Methylation-associated miR-193b silencing activates master drivers of aggressive prostate cancer.Mol Oncol2019
31152158Publisher Correction: The long tail of oncogenic drivers in prostate cancer.Nat Genet2019
31061129Genomic correlates of clinical outcome in advanced prostate cancer.Proc Natl Acad Sci U S A2019
30996073A Novel Mechanism Driving Poor-Prognosis Prostate Cancer: Overexpression of the DNA Repair Gene, Ribonucleotide Reductase Small Subunit M2 (RRM2).Clin Cancer Res2019
30373752Prospective Genotyping of Hepatocellular Carcinoma: Clinical Implications of Next-Generation Sequencing for Matching Patients to Targeted and Immune Therapies.Clin Cancer Res2019
30290956Genomic Differences Between "Primary" and "Secondary" Muscle-invasive Bladder Cancer as a Basis for Disparate Outcomes to Cisplatin-based Neoadjuvant Chemotherapy.Eur Urol2019
30589920Analysis of the Prevalence of Microsatellite Instability in Prostate Cancer and Response to Immune Checkpoint Blockade.JAMA Oncol2019
29625050Oncogenic Signaling Pathways in The Cancer Genome Atlas.Cell2018
29863497ATR inhibition controls aggressive prostate tumors deficient in Y-linked histone demethylase KDM5D.J Clin Invest2018
30179225Immunogenomic analyses associate immunological alterations with mismatch repair defects in prostate cancer.J Clin Invest2018
30013179Genome doubling shapes the evolution and prognosis of advanced cancers.Nat Genet2018
29898407Integrated Molecular Characterization of Testicular Germ Cell Tumors.Cell Rep2018
30382943Immunogenomic analyses associate immunological alterations with mismatch repair defects in prostate cancer.J Clin Invest2018
29617658Machine Learning Detects Pan-cancer Ras Pathway Activation in The Cancer Genome Atlas.Cell Rep2018
29610475The long tail of oncogenic drivers in prostate cancer.Nat Genet2018
29664468Unifying cancer and normal RNA sequencing data from different sources.Sci Data2018
29540675Expression of lncRNA MIR222HG co-transcribed from the miR-221/222 gene promoter facilitates the development of castration-resistant prostate cancer.Oncogenesis2018
28891793Regulation of the glucocorticoid receptor via a BET-dependent enhancer drives antiandrogen resistance in prostate cancer.Elife2017
28174235An Integrated Approach Identifies Mediators of Local Recurrence in Head and Neck Squamous Carcinoma.Clin Cancer Res2017
28778953CDK6 protects epithelial ovarian cancer from platinum-induced death via FOXO3 regulation.EMBO Mol Med2017
28614298ERF mutations reveal a balance of ETS factors controlling prostate oncogenesis.Nature2017
28825054Prospective Genomic Profiling of Prostate Cancer Across Disease States Reveals Germline and Somatic Alterations That May Affect Clinical Decision Making.JCO Precis Oncol2017
27103403Comprehensive Molecular Characterization of Salivary Duct Carcinoma Reveals Actionable Targets and Similarity to Apocrine Breast Cancer.Clin Cancer Res2016
27182557Multiplexed immunofluorescence delineates proteomic cancer cell states associated with metabolism.JCI Insight2016
26876200Radiotherapy-induced miR-223 prevents relapse of breast cancer by targeting the EGF pathway.Oncogene2016
26512117p27kip1 controls H-Ras/MAPK activation and cell cycle entry via modulation of MT stability.Proc Natl Acad Sci U S A2015
24727437Contact inhibition modulates intracellular levels of miR-223 in a p27kip1-dependent manner.Oncotarget2014
24661902p70S6 kinase mediates breast cancer cell survival in response to surgical wound fluid stimulation.Mol Oncol2014
23899505Inhibition of breast cancer local relapse by targeting p70S6 kinase activity.J Mol Cell Biol2013
  • 1 - 42 of 42

Recommended Authors

Yunpeng Gao
University of Texas Southwestern Medical Center at Dallas
Career Start Year 2017
Number of shared co-authors 5
Michael Sigouros
Caryl and Israel Englander Institute for Precision Medicine
Career Start Year 2017
Number of shared co-authors 18
Job van Riet
Erasmus MC Cancer Institute
Career Start Year 2017
Number of shared co-authors 1
Rohan Bareja
Case Western Reserve University
Career Start Year 2017
Number of shared co-authors 20
Vincent Huang
Ontario Institute for Cancer Research
Career Start Year 2016
Number of shared co-authors 6
Takafumi N Yamaguchi
University of California los angeles
Career Start Year 2015
Number of shared co-authors 15
Raunak Shrestha
University of California San Francisco
Career Start Year 2014
Number of shared co-authors 5
Yari Ciani
University of Trento
Career Start Year 2012
Number of shared co-authors 4
Matti Annala
University of British Columbia
Career Start Year 2011
Number of shared co-authors 10
Julie Livingstone
University of California los angeles
Career Start Year 2011
Number of shared co-authors 9
Haiyang Guo
the Second Hospital, Cheeloo College of Medicine, Shandong University
Career Start Year 2011
Number of shared co-authors 9
Adam G Sowalsky
National Cancer Institute
Career Start Year 2010
Number of shared co-authors 17
Gunes Gundem
Memorial Sloan Kettering Cancer Center
Career Start Year 2010
Number of shared co-authors 13
Mohammed Alshalalfa
University of Miami Miller School of Medicine/Sylvester Comprehensive Cancer Center
Career Start Year 2009
Number of shared co-authors 21
David A Quigley
University of California-San Francisco
Career Start Year 2008
Number of shared co-authors 18
Anne Haegert
University of British Columbia
Career Start Year 2008
Number of shared co-authors 9
John R Prensner
University of Michigan ann arbor
Career Start Year 2007
Number of shared co-authors 23
Alexander W Wyatt
University of British Columbia
Career Start Year 2007
Number of shared co-authors 21
Elai Davicioni
Veracyte Inc.
Career Start Year 2006
Number of shared co-authors 37
Alok K Tewari
Dana-Farber Cancer Institute, Harvard Medical School
Career Start Year 2005
Number of shared co-authors 9
Peter Horak
German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT)
Career Start Year 2003
Number of shared co-authors 3
Tesa M Severson
Oncode Institute, The Netherlands Cancer Institute
Career Start Year 2002
Number of shared co-authors 11
Michael Fraser
Princess Margaret Cancer Centre, University Health Network
Career Start Year 2001
Number of shared co-authors 18
Sooryanarayana Varambally
University of Alabama at Birmingham, USA O'Neal Comprehensive Cancer Center
Career Start Year 2001
Number of shared co-authors 21
Yuzhuo Wang
University of British Columbia
Career Start Year 2000
Number of shared co-authors 19
Xuhong Cao
Michigan Center for Translational Pathology.
Career Start Year 1999
Number of shared co-authors 44
Joshi J Alumkal
Rogel Cancer Center, University of Michigan ann arbor
Career Start Year 1999
Number of shared co-authors 32
Phillip G Febbo
Illumina Inc.
Career Start Year 1997
Number of shared co-authors 20
Felix Y Feng
UCSF Medical Center-Mount Zion
Career Start Year 1997
Number of shared co-authors 58
Luigi Marchionni
Weill-Cornell School of Medicine
Career Start Year 1989
Number of shared co-authors 13

Collaborators

Nikolaus Schultz
Memorial Sloan Kettering Cancer Center
Co-authored papers 20
Wassim Abida
Memorial Sloan Kettering Cancer Center
Co-authored papers 11
Philip W Kantoff
Memorial Sloan Kettering Cancer Center
Co-authored papers 11
Charles L Sawyers
Memorial Sloan Kettering Cancer Center
Co-authored papers 10
Howard I Scher
Memorial Sloan Kettering Cancer Center
Co-authored papers 8
Michael F Berger
Co-authored papers 6
Peter S Nelson
Fred Hutchinson Cancer Center
Co-authored papers 6
Barry S Taylor
Memorial Sloan Kettering Cancer Center
Co-authored papers 6
Eliezer M Van Allen
Dana-Farber Cancer Institute
Co-authored papers 6
Dan R Robinson
Michigan Center for Translational Pathology, University of Michigan ann arbor
Co-authored papers 5
Mary-Ellen Taplin
Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute
Co-authored papers 5
Walid K Chatila
Memorial Sloan Kettering Cancer Center
Co-authored papers 5
Arul M Chinnaiyan
University of Michigan Medical School.
Co-authored papers 5
Himisha Beltran
Dana-Farber Cancer Institute
Co-authored papers 5
Johann S de Bono
The Institute for Cancer Research
Co-authored papers 5
Mark A Rubin
University of Bern
Co-authored papers 5
Colin C Pritchard
University of Washington, USA Brotman Baty Institute for Precision Medicine
Co-authored papers 5
Jianjiong Gao
Memorial Sloan Kettering Cancer Center
Co-authored papers 5
Ritika Kundra
Memorial Sloan Kettering Cancer Center
Co-authored papers 5
Susana Miranda
The Institute of Cancer Research
Co-authored papers 5
Debyani Chakravarty
Memorial Sloan Kettering Cancer Center
Co-authored papers 4
Stephanie A Wankowicz
University of California San Francisco
Co-authored papers 4
Victor E Reuter
Memorial Sloan Kettering Cancer Center
Co-authored papers 4
Zafeiris Zafeiriou
Theageneion Anticancer Hospital
Co-authored papers 4
Michael J Morris
Memorial Sloan Kettering Cancer Center
Co-authored papers 3
Yi-Mi Wu
University of Michigan Medical School ann arbor
Co-authored papers 3
Francisco Vega
The University of Texas MD Anderson Cancer Center
Co-authored papers 3
Suzanne Carreira
The Institute of Cancer Research
Co-authored papers 3
Bruce Montgomery
Fred Hutchinson Cancer Center, University of Washington
Co-authored papers 3
Joaquin Mateo
Vall d'Hebron Institute of Oncology, Vall d'Hebron University Hospital Campus
Co-authored papers 3
Release 1.2